about
The role of androgens in experimental rodent mammary carcinogenesisBreastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysisA comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese womenCharacterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian WomenAndrogen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinomaThe latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markersIs the future of personalized therapy in triple-negative breast cancer based on molecular subtype?Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers.Phase two steroid metabolism and its roles in breast and prostate cancer patientsDown-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysisRole of the androgen receptor in triple-negative breast cancer.Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.AR Signaling in Breast Cancer.Receptor-based targeting of therapeutics.Disparities in breast cancer and african ancestry: a global perspective.In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines.MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.
P2860
Q26864598-CCA7786C-A403-407B-BC41-206E499D6A86Q28085555-B7099A22-0305-4739-AE6E-9753DF1D3AA4Q33618290-82F8F27F-D491-49E9-871C-A864A45C63F1Q33697429-10898879-D856-485C-9969-94424F305347Q33776271-444A0EB5-C144-4B74-8137-36CF63DBE211Q34258373-C32B7986-75F8-4AE7-A7C5-BCEA623C7973Q34476337-9265E7D3-4191-433E-9F0C-8F5FC962D9E9Q35088745-19288599-AF94-478B-A42B-06E825C5CBCAQ35713540-DA6B6809-347D-4E24-BCEE-E2E66D18BE19Q37107334-5D9AD704-4A92-43EF-8188-DA0A660BC464Q37142561-23093AA3-1C78-4056-B3BA-CA60E57D7711Q37534790-F17C4ACD-3593-40DA-80D6-D1A22955C078Q37564779-2468C21D-B63D-4DFB-8E4F-4F77556907B7Q37573317-5C7A862E-17C0-4AC7-8F49-DC26F494F696Q37645090-D76E27F2-340F-4BFB-8416-419A1A8250F2Q37721492-23317FF5-9DFF-4B8F-A861-367F3427EC20Q38084739-1A354C1A-85B8-4833-8EAF-DCE3B3FF9A77Q38339360-E2AB9E21-6686-4551-8AD9-7741D0E4224EQ38673886-471DAD5D-6E8B-4CF6-AF2E-8EA756A5F85CQ38962923-1EBF7D0B-8748-4D5C-A348-4DE2198EAB8DQ38975595-C477F6D6-4BDB-41F9-B7BB-428B10B111A3Q39214999-E12AB613-9E5C-45E6-9388-256539C7732CQ40453986-B5863B13-BFB5-4410-AE2F-B67A294EEB58Q40853453-EB238619-61D1-45A8-BD02-1C56359B21F3Q41346691-8B8CE016-7718-4183-9E9D-F901976F3927Q44103718-AD9523C1-8315-4C1F-8FD5-288D21D8AC42Q46388405-2ACB4C10-9188-48AE-8A8F-B17C3AA59AF2Q48229904-D5CE8599-C527-4B83-A2F5-F1A8B6BC33A7Q50852120-03BACB0F-AC45-4CD5-A1B0-3A93AAC78353Q53122691-5F004E8B-8BE1-4118-94CC-BDC014599B9CQ54328011-949DE71C-4AC2-4CFF-9CB1-AE18A141CA42Q55266544-9EDDAF06-D137-401C-BCB4-841275744C70
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Androgen receptor in triple negative breast cancer.
@en
type
label
Androgen receptor in triple negative breast cancer.
@en
prefLabel
Androgen receptor in triple negative breast cancer.
@en
P2093
P1476
Androgen receptor in triple negative breast cancer
@en
P2093
P356
10.1016/J.JSBMB.2012.08.007
P577
2012-09-05T00:00:00Z